APA (7th ed.) Citation

R, B., DW, L., OB, P., DO, A., RJ, A., & E, A. (2017). Disulfiram overcomes bortezomib and cytarabine resistance in Down-syndrome-associated acute myeloid leukemia cells. Journal of experimental & clinical cancer research : CR, 36(1), 22. https://doi.org/10.1186/s13046-017-0493-5

Chicago Style (17th ed.) Citation

R, Bista, Lee DW, Pepper OB, Azorsa DO, Arceci RJ, and Aleem E. "Disulfiram Overcomes Bortezomib and Cytarabine Resistance in Down-syndrome-associated Acute Myeloid Leukemia Cells." Journal of Experimental & Clinical Cancer Research : CR 36, no. 1 (2017): 22. https://doi.org/10.1186/s13046-017-0493-5.

MLA (9th ed.) Citation

R, Bista, et al. "Disulfiram Overcomes Bortezomib and Cytarabine Resistance in Down-syndrome-associated Acute Myeloid Leukemia Cells." Journal of Experimental & Clinical Cancer Research : CR, vol. 36, no. 1, 2017, p. 22, https://doi.org/10.1186/s13046-017-0493-5.